相关实验视频
Updated: May 17, 2025

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.0K
在肥胖儿童中使用米达佐拉姆的生理基础和人口药动力学建模,使用现实世界的数据
Sean McCann1, Victória E Helfer1, Stephen J Balevic2
1Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Clinical and translational science
|May 14, 2025
概括
这项研究检查了儿童的米达佐拉姆 (一种镇静剂) 剂量,发现肥胖稍微增加了药物暴露. 药物动力学建模表明,基于体重的剂量是关键,肥胖和非肥胖儿童之间的差异很小.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科医学 儿科医学
- 计算生物学 计算生物学
背景情况:
- 药物清除的个体间变异使儿科剂量复杂化.
- 米达佐拉姆是儿童常用的镇静剂,但其剂量-暴露关系尚未完全理解.
- 肥胖可能会显著影响儿童中的米达佐拉姆的药理动力学.
研究的目的:
- 通过两种建模策略,评估肥胖或不肥胖儿童的米达佐拉姆剂量暴露.
- 评估肥胖状况是否解释了米达佐拉姆清除的个体间变异.
- 为了在患有或没有肥胖的儿科群体中比较模拟的米达佐拉姆暴露量.
主要方法:
- 使用93名儿童164个血度的人口药理动力学建模.
- 同变量分析以确定影响米达佐拉姆清除的因素.
- 使用PK-Sim软件与虚拟儿科肥胖人口集成的基于生理学上的药理动力学 (PBPK) 建模.
主要成果:
- 同变量建模确定了体重是影响米达佐拉姆清除的主要因素.
- 种群药动力学模型显示高个体间变异性 (CV 175%) 和残留变异性 (50.4%).
- 基于生理学上的药理动力学建模模拟预测,在基于体重的剂量上,肥胖儿童的米达佐拉姆暴露量会略微增加 (<20%).
结论:
- 体重是儿童米达佐拉姆清除的主要决定因素.
- 肥胖与使用基于体重的剂量时,米达佐拉姆暴露的轻微增加有关.
- 结合的药理动力学和PBPK建模有效地比较不同儿科群体的模拟药物暴露.
相关概念视频
Analysis of Population Pharmacokinetic Data
203
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
203
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
53
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
53
Pharmacokinetic Models: Overview
518
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
518
Pharmacokinetic Models: Comparison and Selection Criterion
29
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
29
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
69
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
69
Model Approaches for Pharmacokinetic Data: Compartment Models
61
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
61

